Accuracy of Physical Examination and Imaging Findings for the Diagnosis of Elevated Intracranial Pressure.

Abstract

LR+: 2.0 for pupillary dilation LR+: 2.20 for compression or absence of the basal cisterns on CT LR+: 1.92 for midline shift > 10 mm on CT LR−: 0.84 for pupillary dilation LR−: 0.23 for compression or absence of the basal cisterns on CT LR−: 0.89 for midline shift > 10 mm on CT Elevated intracranial pressure (ICP) is a common but severe complication of several medical and traumatic conditions.1, 2 Prolonged increases in ICP are associated with poor patient outcomes in a variety of conditions, including traumatic brain injury (TBI), spontaneous subarachnoid or intracerebral hemorrhage, space-occupying lesion, meningitis, cerebral infarct, and cerebral edema from hepatic encephalopathy.3-5 Invasive ICP monitoring is the reference standard for cases suspected of increased ICP but is not universally available and has several potential complications, including intracranial infection and hemorrhage.5, 6 Consequently, clinicians must often rely on noninvasive methods for assessing increased ICP. The systematic review and meta-analysis discussed here included all retrospective, prospective observational, and randomized controlled trials of adult patients (age ≥ 16 years) in the emergency department or intensive care unit that assessed physical examination findings, brain computed tomography (CT), ocular nerve sheath diameter on ultrasound, or transcranial Doppler indices.7 The reference standard consisted of either an ICP reading> 20 mm Hg on invasive ICP monitoring or craniectomy with an operative diagnosis of elevated ICP. The primary outcome was the diagnostic accuracy of the aforementioned tests for diagnosing increased ICP. The systematic review identified 40 studies (n = 5,123 patients) who met the inclusion criteria. Twenty-four studies were prospective cohort studies, 15 were retrospective, and one was a randomized controlled trial. Twenty studies included patients with TBI, three subarachnoid hemorrhage, two intracerebral hemorrhage, two hepatic failure, one ischemic stroke, and 12 mixed populations of primary brain injury. Only three physical examination findings (pupillary dilatation, motor posturing, and altered mental status) had adequate relevant studies to allow for a meta-analysis. Table 1 demonstrates the findings associated with elevated ICP. Measuring ocular nerve sheath diameter with ultrasound appeared to have a high discriminatory power with the pooled area under the receiver operating characteristic (AUROC) curve of 0.94 (95% confidence interval [CI] = 0.91 to 0.96). The sensitivity and specificity of the test were dependent on the cutoff used for increased optic nerve sheath in each study, precluding the possibility of meta-analysis to calculate pooled sensitivity and specificity. Authors calculated AUROC values for transcranial doppler pulsatility index (TCD-PI) to detect ICP ≥ 20 mm Hg based on three studies, finding a pooled AUROC value of 0.85 (95% CI = 0.78 to 0.91) with use of combined TCD arterial blood pressure methods. This study has several important limitations. Most of the included studies were relatively small, with only 13 studies enrolling more than 100 people. Additionally, the prevalence varied significantly between studies which may lead to spectrum bias, and evidence quality for findings suggestive of elevated ICP was predominantly low or moderate, with only midline shift > 10 mm on CT associated with high evidence quality. Nearly one-third of the studies were retrospective in nature. There was also significant heterogeneity with regard to the etiology and severity of the associated injuries, with no definition of the search strategy pertaining to the specific etiology of elevated ICP. Clinical signs were evaluated independently, which is not typical of clinical practice, and it is unclear how the diagnostic accuracy would change when using combinations of findings. Moreover, the inclusion of studies with either invasive monitoring or intraoperative diagnosis may lead to misclassification of the target condition in the latter case. Advances in imaging quality may limit the external validity of older studies with regard to current imaging. Furthermore, while 10 studies (1,035 patients) evaluated ocular nerve sheath diameter, the variations in ocular nerve sheath diameter thresholds precluded the ability to perform meta-analyses on this group. Finally, there were limited data on transcranial Doppler with differences in both the parameters assessed between studies. Based on the existing evidence, most findings are insufficiently sensitive or specific for the diagnosis of increased ICP. Therefore, physical examination findings, CT, ocular nerve sheath diameter, and transcranial Doppler do not appear to be reliable in identifying or excluding increased ICP.